2013-05-15T11:39:56-05:00 2012-06-30 346565596 ERNST & YOUNG US LLP 75 BEATTIE PLACE SUITE 800 GREENVILLE SC 29601 990 2011-07-01 592451713 H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 JANENE CULUMBER 8137451329 2013-05-15 0 EMILY STANCIL P00115650 8642425740 2011 2016-02-24 21:20:13Z WILLIAM S DALTON MD PHD 12902 MAGNOLIA DRIVE TAMPA FL 33612 133028805 0 X WWW.MOFFITT.ORG X 1984 FL TO PROMOTE AND SUPPORT THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 21 21 1567 254 372718 0 111419521 101384269 1715798 1275301 2376988 2248356 1272356 1886708 116784663 106794634 233784 547343 0 0 115492094 80296883 0 0 0 20514455 49354531 136240333 130198757 -19455670 -23404123 520418415 489005713 289922597 267920083 230495818 221085630 X TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 0 0 99532657 547343 1848680 THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS A RECOGNIZED LEADER IN FOCUSED, INNOVATIVE CANCER RESEARCH, A MAJOR REGIONAL ONCOLOGY REFERRAL CENTER, AND A NATIONAL CANCER INSTITUTE DESIGNATED COMPREHENSIVE CANCER CENTER.BASED ON ITS SINGULAR MISSION - TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER - THE CANCER CENTER'S RESEARCH ACTIVITIES RELATE PRIMARILY TO THE AREAS OF BASIC SCIENCE, CANCER PREVENTION AND CONTROL, TRANSLATIONAL SCIENCE, PRE-CLINICAL AND CLINICAL INVESTIGATIONS, AND PROVIDING MANAGEMENT AND OTHER SUPPORT SERVICES AS THE SOLE CORPORATE MEMBER AND PARENT FOR THE FOLLOWING SUBSIDIARY CORPORATIONS: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. (THE HOSPITAL) WHICH PROVIDES MEDICAL AND HOSPITAL CARE, MEDICAL EDUCATION AND TRAINING, AND CLINICAL (PATIENT-RELATED) RESEARCH IN MAINTAINING HEALTH, AND PREVENTING, DETECTING, AND TREATING CANCER;H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. (MOFFITT MEDICAL GROUP) WHICH EMPLOYS AND MANAGES PHYSICIANS AND OTHER MEDICAL PROFESSIONALS WHO STAFF THE HOSPITAL, AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER; ANDH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. (THE FOUNDATION) WHICH IS THE PRINCIPAL FUND-RAISING ORGANIZATION FOR THE CANCER CENTER AND ITS SUBSIDIARIES.THE CANCER CENTER'S MULTIDISCIPLINARY CLINICAL PROGRAM STRUCTURE AND OPEN LABORATORY ARCHITECTURE PROVIDE AN ENVIRONMENT CONDUCIVE FOR TRAINING FUTURE SCIENTIFIC AND CLINICAL LEADERS IN ONCOLOGY, AND REFLECT THE CANCER CENTER'S COMMITMENT TO COLLABORATION IN ALL ASPECTS OF CANCER RESEARCH. 99532657 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 1 1 1 0 0 1 293 0 1 1567 1 1 1 0 0 0 0 0 0 0 0 0 X 21 21 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 1 1 1 0 X JANENE CULUMBER 8137451329 12902 MAGNOLIA DR TAMPA FL 33612 X ROBERT ROTHMAN 1.00 X X 0 0 0 SENATOR CONNIE MACK 1.00 X X 0 0 0 TIMOTHY J ADAMS 1.00 X X 0 0 0 DONALD D BUCHANAN 1.00 X X 0 0 0 CARLOS ALFONSO 1.00 X 0 0 0 JORGE ARRIZURIETA 1.00 X 0 0 0 ANGELA BIEVER 1.00 X 0 0 0 THE HONORABLE CARL CARPENTER 1.00 X 0 0 0 THEODORE J COUCH SR 1.00 X 0 0 0 EDWARD DEBARTOLO 1.00 X 0 0 0 EDWARD C DROSTE 1.00 X 0 0 0 CECELIA D FERMAN 1.00 X 0 0 0 JUDY L GENSHAFT PHD 1.00 X 0 0 0 THE HONORABLE JOHN A GRANT 1.00 X 0 0 0 THE HONORABLE JAMES T HARGRETT 1.00 X 0 0 0 REV MONSIGNOR LAURENCE HIGGINS 1.00 X 0 0 0 BENJAMIN H HILL III ESQ 1.00 X 0 0 0 BETH A HOUGHTON 1.00 X 0 0 0 GARY W LITMAN PHD 1.00 X 0 0 0 THE HONORABLE H LEE MOFFITT 1.00 X 0 0 0 JOHN RAMIL 1.00 X 0 0 0 WILLIAM S DALTON 24.00 X 1283434 0 75263 LOUIS D DE LA PARTE 17.00 X 472514 0 39484 JOHN A KOLOSKY 17.00 X 776151 0 43734 ALAN F LIST 10.00 X 0 679052 42871 JAMES J MULAY 54.00 X 460346 0 37261 WARREN J PLEDGER 55.00 X 574684 0 43184 THOMAS A SELLERS 55.00 X 621238 0 47380 DANIEL M SULLIVAN 41.00 X 0 564110 45325 YVETTE LYONS TREMONTI 22.00 X 365086 0 43146 MICHAEL K BENEDICT 55.00 X 297398 0 40918 JANENE CULUMBER 17.00 X 456168 0 35159 B LEE GREEN 55.00 X 258177 0 33800 DEAN R HEAD 55.00 X 233893 0 26416 DORTE HEIMBECK 55.00 X 119531 0 16357 JOE S HICE 55.00 X 201312 0 9097 MARK F HULSE 55.00 X 317987 0 37128 JOANNE L OLSON 55.00 X 116689 0 3661 DANA E ROLLISON 55.00 X 180717 0 31390 W J WILSON 55.00 X 273699 0 27036 LYNN C MOSCINSKI 1.00 X 0 492923 32298 MICHELE A TALKA 55.00 X 180173 0 27686 SRIKUMAR CHELLAPPAN 55.00 X 318408 0 41849 JULIE Y DJEU 54.00 X 284038 0 36166 ROBERT J GILLIES 55.00 X 404733 0 41340 MARK G SCHIPPITS 55.00 X 270796 0 34434 SAID M SEBTI 55.00 X 440974 0 40687 NICOLAS C PORTER 55.00 X 554253 0 40029 BRAULIO VICENTE JR 0.00 X 0 392600 44121 W MICHAEL ALBERTS 0.00 X 0 430071 44513 TIMOTHY J YEATMAN 0.00 X 0 524466 34291 9462399 3083222 1096024 172 1 1 0 SHUMAKER LOOP & KENDRICK LLP 101 E KENNEDY BLVD STE 2800 TAMPA FL 33602 LEGAL SERVICES 1558045 ERNST & YOUNG US LLP 200 PLAZA DRIVE SECAUCUS NJ 07094 AUDIT & TAX SERVICES 692030 THEO EXECUTIVE GROUP LLC 909 LAKE CAROLYN PKWY STE 775 IRVING TX 75039 ADVISORY SERVICES 588506 DELOITTE CONSULTING LLP 4022 SELLS DRIVE HERMITAGE TN 37076 CONSULTING SERVICES 587737 TAMPA BAY RAYS BASEBALL LTD ONE TROPICANA DRIVE ST PETERSBURG FL 33705 ADVERTISING & PROMOTIONAL SERVICES 204106 13 17972713 71596048 11815508 3962887 101384269 REIMBURSEMENTS 541900 1052801 1052801 CYCLOTRON 900099 120000 120000 CANCER REGISTRY 900099 102500 102500 1275301 1732749 1732749 573379 573379 26176399 26184873 49298 -8474 -49298 -57772 -57772 SERIES 2002B BONDS 523000 505397 505397 SERIES 2002A BONDS 523000 372598 372598 M2GEN LEASE PAYMENTS 900003 321212 321212 687501 51506 635995 1886708 106794634 1848680 372718 3188967 X 547343 547343 8721462 4049317 4672145 529265 529265 56968886 44908072 12060814 3377931 2469005 908926 6916149 5505130 1411019 3783190 2637578 1145612 969379 969379 55659 55659 113495 113495 104007 104007 2518781 1840554 678227 744397 54145 690252 9919277 7020794 2898483 2152737 2152737 4381398 1291500 3089898 1142965 991753 151212 1176790 16433 1160357 7607724 701042 6906682 67907 5582 62325 ALLOC OF INTERCO EXP 0 14712556 -14712556 PURCHASED SERVICES 7258331 5510641 1747690 SUBCONTRACTS 4960581 4960581 SPECIAL CONTRACTS 826728 773145 53583 5354375 1537486 3816889 130198757 99532657 30666100 0 36644638 11763550 3941855 15241379 9186786 8520397 88674 22500 15679563 18463046 585935180 268148266 327745901 317786914 127130998 117207927 520418415 489005713 77634851 62308739 208480 124418 210026076 202460076 2053190 3026850 289922597 267920083 X 189844672 180482408 40651146 40603222 230495818 221085630 520418415 489005713 X -23404123 13993935 X 0 1 1 X 1 1 X 112810991 116278541 94099419 111419521 101384269 535992741 112810991 116278541 94099419 111419521 101384269 535992741 535992741 605108 419553 104679 2383082 2306128 5818550 4830 42103 1970 51506 100409 598727 675538 490884 1270386 1513990 4549525 546461225 9012655 0.98080 0.98590 X Schedule A, Part IV, Supplemental Information: SCHEDULE A, PART II, LINE 10, EXPLANATION FOR OTHER INCOME: OTHER INCOME IS RELATED TO SERIES 2002A AND SERIES 2002B BONDS AS WELL AS LICENSE FEES. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 20371 1 853 0 1 143612 0 1 3895 168731 0 Explanation of Lobbying Activities: Part II-B, Line 1: THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS THREE NON-PROFIT SUBSIDIARY CORPORATIONS ("CORPORATION") WERE CREATED TO GOVERN AND OPERATE THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE ("INSTITUTE") PURSUANT TO SECTION 1004.43, FLORIDA STATUTES. AMONG OTHER THINGS, SECTION 1004.43, FLORIDA STATUTES PROVIDES: (1) THAT THE CORPORATION SHALL ENTER INTO AN AGREEMENT WITH THE STATE BOARD OF EDUCATION FOR THE UTILIZATION OF FACILITIES ON THE CAMPUS OF THE UNIVERSITY OF SOUTH FLORIDA; (2) THAT THE CORPORATION SUBMIT ANNUAL POST AUDITS OF ITS FINANCIAL ACCOUNTS TO THE AUDITOR GENERAL OF THE STATE OF FLORIDA AND THE BOARD OF GOVERNORS FOR THEIR REVIEW; AND (3) THAT THE CORPORATION'S CEO REPORT TO THE BOARD OF GOVERNORS OR ITS DESIGNEE AND PROVIDE COPIES OF THE INSTITUTE'S ANNUAL REPORT TO THE GOVERNOR OF THE STATE OF FLORIDA, THE CABINET, THE PRESIDENT OF THE SENATE, THE SPEAKER OF THE HOUSE AND THE CHAIR OF THE BOARD OF GOVERNORS. ALTHOUGH THE CORPORATION IS A PRIVATE ENTITY, IT IS NONETHELESS SUBJECT TO THE STATE OF FLORIDA'S PUBLIC RECORDS AND THE PUBLIC MEETINGS LAWS. THE CORPORATION ALSO RELIES ON ANNUAL APPROPRIATIONS BY THE LEGISLATURE OF THE STATE OF FLORIDA AND GRANTS FROM VARIOUS LOCAL, STATE AND FEDERAL AGENCIES FOR OPERATION AND MAINTENANCE OF ITS FACILITIES AND FOR SPECIFIC RESEARCH AND CLINICAL PROGRAMS. FOR THESE REASONS, THE CORPORATION FROM TIME TO TIME ENGAGES LOBBYISTS AND OTHER CONSULTANTS; (1) TO ASSIST IT IN COMPLYING WITH ITS REPORTING REQUIREMENTS TO THE STATE OF FLORIDA UNDER SECTION 1004.43, FLORIDA STATUTES; (2) TO MONITOR LEGISLATIVE AND EXECUTIVE BRANCH ACTION AT LOCAL, STATE AND FEDERAL LEVELS OF GOVERNMENT WHICH IMPACT ITS OPERATION AND THE FULFILLMENT OF ITS MISSION; AND (3) TO INFLUENCE LEGISLATION IN FURTHERANCE OF ITS MISSION IN THE AREAS OF CANCER RESEARCH AND TREATMENT, THE TEACHING AND TRAINING OF HEALTH CARE PROFESSIONALS AND COMMUNITY EDUCATION AND OUTREACH ACTIVITIES. THE CORPORATION DOES NOT ENGAGE IN ANY ACTIVITIES TO SUPPORT OR OPPOSE ANY CANDIDATE FOR PUBLIC OFFICE. Part IV, Supplemental Information: OTHER ACTIVITIES, LINE 1i: THE OTHER ACTIVITIES AMOUNT LISTED ON LINE 1i IS COMPRISED OF EXPENSES RELATED TO ORCHESTRATING CONTACT BETWEEN GRASSROOTS SUPPORTERS AND ELECTED OFFICIALS TO PROMOTE THE INSTITUTION'S LEGISLATIVE INITIATIVES. 9306184 9306184 344009554 113411439 230598115 3898175 2907417 990758 216507749 151829410 64678339 12213518 12213518 317786914 BOND ISSUE COSTS 1348456 INTEREST IN NET ASSETS OF FOUNDATION 22954000 ASSETS WHOSE USE IS LIMITED 92356791 OTHER ASSETS 48580 INVESTMENT IN MTC 500000 INVESTMENT IN M2GEN 100 117207927 LEASE OBLIGATIONS 3026850 3026850 Description of Uncertain Tax Positions Under FIN 48: Part X: THE CANCER CENTER RECOGNIZES UNCERTAIN TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT (I.E., GREATER THAN 50% LIKELIHOOD OF RECEIVING BENEFIT) AND RECORDS THESE BENEFITS AT THE AMOUNT MOST LIKELY TO BE REALIZED ASSUMING A REVIEW BY TAX AUTHORITIES HAVING ALL RELEVANT INFORMATION AND APPLYING CURRENT CONVENTIONS. THE CANCER CENTER HAS NO SIGNIFICANT UNRECOGNIZED TAX BENEFITS AND DOES NOT BELIEVE THAT THERE WILL BE ANY MATERIAL CHANGES IN THE CANCER CENTER'S UNRECOGNIZED TAX POSITION OVER THE NEXT 12 MONTHS. 1 AMERICAN CANCER SOCIETY INC 250 WILLIAMS STREET NW SUITE 400 ATLANTA GA 30303 131788491 501(C)(3) 15000 SPONSORSHIP THE V FOUNDATION 106 TOWERVIEW COURT CARY NC 27513 133705951 501(C)(3) 30000 SPONSORSHIP DEBARTOLO FAMILY FOUNDATION INC 15436 N FLORIDA AVE SUITE 200 TAMPA FL 33613 311739677 501(C)(3) 8500 SPONSORSHIP GREATER TAMPA CHAMBER OF COMMERCE INC 201 N FRANKLIN STREET SUITE 201 TAMPA FL 33602 590474960 501(C)(6) 8850 SPONSORSHIP TAMPA BAY PARTNERSHIP FOR REGIONAL ECONOMIC DEVELOPMENT INC 4300 W CYPRESS STREET SUITE 700 TAMPA FL 33607 593248071 501(C)(3) 26500 SPONSORSHIP FLORIDA SUNCOAST AFFILIATE OF SUSAN G KOMEN FOR THE CURE PO BOX 12848 ST PETERSBURG FL 33733 752870702 501(C)(3) 7500 SPONSORSHIP USF WUSF-TV 4202 E FOWLER AVE TAMPA FL 33620 593102112 501(C)(3) 25000 SPONSORSHIP THE LEUKEMIA & LYMPHOMA SOCIETY INC 1311 MAMARONECK AVE WHITE PLAINS NY 10605 135644916 501(C)(3) 10000 SPONSORSHIP THE HEALTH SUPPORT NETWORK INC 5481 COMMUNICATIONS PARKWAY SARASOTA FL 34240 650495067 501(C)(3) 10000 SPONSORSHIP SILICOM VENTURES LLC 1456 FOWLER LANE LOS ALTOS CA 94024 770570098 10000 SPONSORSHIP COMMUNITY CONVERSATIONS LLC 3602 E GROVE STREET TAMPA FL 33610 455347868 30000 SPONSORSHIP TAMPA INNOVATION ALLIANCE INC 3100 E FLETCHER AVE TAMPA FL 33613 611692291 501(C)(6) 25000 SPONSORSHIP H LEE MOFFITT CC&RI HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 501(C)(3) 232427 209617 FMV EQUIPMENT INTERCOMPANY SUPPORT H LEE MOFFITT CC&RI LIFETIME CSC INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238640 501(C)(3) 11948 INTERCOMPANY SUPPORT 10 4 Procedure for Monitoring Grants in the U.S.: Part I, Line 2: Schedule I, Part I, Line 2: INTERCOMPANY SUPPORT IS ONLY MADE TO RELATED ORGANIZATIONS TO SUPPORT THEIR OPERATIONS. SPONSORSHIPS ARE APPROVED THROUGH THE CHECK REQUEST PROCESS. BECAUSE OF THE NATURE OF THE GRANTS, THE GRANT USE IS NOT MONITORED SINCE THEY ARE GIVEN TO THE ORGANIZATION FOR A SPECIFIC PURPOSE OR EVENT. X X 0 1 X X X X 1 1 0 0 0 1 1 0 0 WILLIAM S DALTON 897989 0 257499 0 127946 0 25603 0 51498 0 1360535 0 0 0 LOUIS D DE LA PARTE 387326 0 82453 0 2735 0 25602 0 19925 0 518041 0 0 0 JOHN A KOLOSKY 597728 0 105953 0 72470 0 25603 0 23816 0 825570 0 0 0 ALAN F LIST 0 538120 0 101468 0 39464 0 25602 0 24413 0 729067 0 0 JAMES J MULAY 375375 0 65469 0 19502 0 24137 0 22623 0 507106 0 0 0 WARREN J PLEDGER 440314 0 77641 0 56729 0 25603 0 27262 0 627549 0 0 0 THOMAS A SELLERS 504657 0 84455 0 32126 0 25602 0 29024 0 675864 0 0 0 DANIEL M SULLIVAN 0 420983 0 71191 0 71936 0 25603 0 26416 0 616129 0 0 YVETTE LYONS TREMONTI 302252 0 47835 0 14999 0 25602 0 23218 0 413906 0 0 0 MICHAEL K BENEDICT 249090 0 33438 0 14870 0 19600 0 28358 0 345356 0 0 0 JANENE CULUMBER 361448 0 53507 0 41213 0 19600 0 21442 0 497210 0 0 0 B LEE GREEN 206480 0 34195 0 17502 0 19369 0 21096 0 298642 0 0 0 DEAN R HEAD 191531 0 32275 0 10087 0 18509 0 14672 0 267074 0 0 0 JOE S HICE 135811 0 35000 0 30501 0 1340 0 11988 0 214640 0 0 0 MARK F HULSE 260164 0 49002 0 8821 0 19600 0 24317 0 361904 0 0 0 DANA E ROLLISON 160106 0 13919 0 6692 0 15021 0 19008 0 214746 0 0 0 W J WILSON 236235 0 20000 0 17464 0 19600 0 12015 0 305314 0 0 0 LYNN C MOSCINSKI 0 399880 0 66747 0 26296 0 25603 0 12270 0 530796 0 0 MICHELE A TALKA 155726 0 16414 0 8033 0 11544 0 18488 0 210205 0 0 0 SRIKUMAR CHELLAPPAN 251632 0 55494 0 11282 0 23833 0 19155 0 361396 0 0 0 JULIE Y DJEU 259017 0 8333 0 16688 0 25602 0 11617 0 321257 0 0 0 ROBERT J GILLIES 323571 0 66982 0 14180 0 25603 0 16960 0 447296 0 0 0 MARK G SCHIPPITS 234761 0 25599 0 10436 0 15313 0 20825 0 306934 0 0 0 SAID M SEBTI 356744 0 66596 0 17634 0 25602 0 16441 0 483017 0 0 0 NICOLAS C PORTER 116710 0 60579 0 376964 0 25603 0 22090 0 601946 0 0 0 BRAULIO VICENTE JR 0 310392 0 58913 0 23295 0 19600 0 31394 0 443594 0 0 W MICHAEL ALBERTS 0 317325 0 61895 0 50851 0 25602 0 24605 0 480278 0 0 TIMOTHY J YEATMAN 0 480318 0 0 0 44148 0 15313 0 24177 0 563956 0 0 Part I, Line 1b PAYMENTS MADE FOR SOCIAL CLUB DUES AND PERSONAL SERVICES ARE APPROVED BY THE JOINT EXECUTIVE COMPENSATION AND BENEFITS COMMITTEE (JEC&BC). PAYMENTS ARE A FIXED AMOUNT BASED ON JOB CLASSIFICATION AND IS DOCUMENTED IN MINUTES OF THE COMMITTEE AND REPORTED BACK TO THE BOARD. Part I, Lines 4a-b NICOLAS C. PORTER RECEIVED $313,196.00 IN SEVERENCE PAYMENTS. THE FOLLOWING INDIVIDUALS PARTICIPATE IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND AMOUNTS LISTED ARE INCLUDED IN THEIR TOTAL COMPENSATION, RESPECTIVELY: WILLIAM M. ALBERTS - $12,960.88 YVETTE M. LYONS TREMONTI - $10,284.80 JANENE J. CULUMBER-$25,830.14 NICOLAS C. PORTER - $23,685.74 JOHN A. KOLOSKY - $44,074.75 WILLIAM S. DALTON - $76,780.72 BRAULIO VICENTE-$9,265.26 DANIEL M. SULLIVAN-$23,622.20 MICHAEL K. BENEDICT - $3,195.53 WARREN J. PLEDGER - $26,721.16 Part I, Line 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON MOFFITT'S ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS RELATED TO NET OPERATING INCOME AND ON DIVISION OR INDIVIDUAL GOALS. NET OPERATING INCOME MUST MEET OR EXCEED A CERTAIN THRESHOLD IN ORDER TO TRIGGER A PAYOUT FOR THE ORGANIZATIONAL GOAL COMPONENTS. HILLSBOROUGH COUNTY INDUSTRIAL DEVELOPMENT AUTHORITY 591293512 43233ADJ2 2007-11-08 118550173 SEE SUPPLEMENTAL SCH K PART IA(f) 0 0 0 HILLSBOROUGH COUNTY INDUSTRIAL DEVELOPMENT AUTHORITY 591293512 2010-09-08 22000000 SEE SUPPLEMENTAL SCH K PART IB(f) 0 0 0 124087097 25052643 1028820 92340395 2010 0 0 0 1 22039726 2497573 345805 19202958 2011 0 0 0 1 0 0 0 0 0.00000 0.00000 0.00000 1 0 0 1 1 0 0.00000 0.00000 0.00000 1 0 0 0 1 SUNTRUST 8.100000000000 1 0 0 0 1 0 0 0 0 FORM 990 SCHEDULE K PART 1A(F) 1. FINANCING THE COST OF CONSTRUCTING AND EQUIPPING A FOUR STORY ADDITION TO THE MAIN CAMPUS OF THE HOSPITAL, TO INCLUDE 36 ADDITIONAL INPATIENT BEDS, RADIATION ONCOLOGY CLINIC PROGRAM EXPANSION WITH THE ADDITION OF TWO NEW VAULTS USED FOR STATE OF THE ART LINEAR ACCELERATORS, CLINICAL LAB AND PATHOLOGY PROGRAM EXPANSION, APPROXIMATELY 40,000 GROSS SQUARE FEET OF FACULTY OFFICE SPACE, AND 1,000 SPACE PARKING GARAGE. 2. FINANCING THE COST OF VARIOUS BACKFILL AND REFURBISHMENT PROJECTS, INCLUDING THE ADDITION OF EIGHT INPATIENT BEDS IN EXISTING SPACE LOCATED AT THE INSTITUTE AND HOSPITAL. FORM 990, SCHEDULE K PART IB(F) 1. PAYING ALL OR A PORTION OF THE COST OF IMPROVEMENT, BUILD-OUT AND EQUIPPING OF CERTAIN CAPITAL IMPROVEMENTS LOCATED ON THE PROJECT SITE AND THE ACQUISITION OF EQUIPMENT, INCLUDING, WITHOUT LIMITATION, THE IMPROVEMENT, BUILD-OUT, DESIGN, RENOVATION AND EQUIPPING OF A CANCER TREATMENT AND IMAGING CENTER TO BE LOCATED ON THE PROJECT SITE; 2. FINANCING AND REFINANCING CERTAIN OTHER CAPITAL COSTS PREVIOUSLY INCURRED BY THE HOSPITAL WITH RESPECT TO SUCH PROJECTS. KIRA HULSE SEE PART V 33626 SEE PART V 0 Form 990, Schedule L, Part IV INTERESTED PERSON: KIRA HULSERELATIONSHIP: FAMILY MEMBER OF MARK F. HULSETRANSACTION DESCRIPTION: COMPENSATION X EQUIPMENT 4 3962887 PURCHASE PRICE 0 0 0 0 Method for Determining Number of Contributors: Part I, Column (b): THE NUMBER OF CONTRIBUTORS REPORTED REFLECTS THE NUMBER OF CONTRIBUTORS, NOT THE NUMBER OF ITEMS CONTRIBUTED. Form 990, Part VI, Section A, line 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON THE INSTITUTE AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. INSTITUTE & MOFFITT GENETICS CORPORATION: DONALD D. BUCHANAN, DIRECTOR THEODORE J. COUCH, DIRECTOR H. LEE MOFFITT, DIRECTOR ROBERT ROTHMAN, DIRECTOR WILLIAM S. DALTON, OFFICER DANIEL M. SULLIVAN, OFFICER LOUIS D. DE LA PARTE, OFFICER JANENE J. CULUMBER, OFFICER INSTITUTE & MOFFITT TECHNOLOGIES CORPORATION: WILLIAM S. DALTON, OFFICER JOHN A. KOLOSKY, OFFICER LOUIS D. DE LA PARTE, OFFICER JANENE J. CULUMBER, OFFICER JAMES J. MULAY, OFFICER YVETTE LYONS TREMONTI, OFFICER Form 990, Part VI, Section B, line 11 PRIOR TO PROVIDING FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, TO THE PARENT-RESEARCH BOARD OF DIRECTORS FOR REVIEW, THE CHIEF FINANCIAL OFFICER REVIEWS THE RETURN. SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED AND ANY NECESSARY CORRECTIONS ARE MADE. PRIOR TO ELECTRONICALLY FILING FORM 990, MOFFITT PARENT-RESEARCH PROVIDES A COPY OF THE RETURN TO THE GOVERNING BODY, GIVING EACH BOARD MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. Form 990, Part VI, Section B, line 12c ON AN ANNUAL BASIS A PRESENTATION IS MADE TO RESEARCH BOARD MEMBERS TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM ATTACHED TO THE POLICY. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS/HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. Form 990, Part VI, Section B, line 15 MOFFITT'S BOARD OF DIRECTORS HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE DIRECTORS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE PERFORMANCE AND COMPENSATION OF MOFFITT EXECUTIVES AND DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS AND DEPARTMENT CHAIRPERSONS. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN AS NEEDED AND DOES AT ITS DISCRETION, ENGAGE OUTSIDE INDEPENDENT, OUTSIDE ADVISORS INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH EXECUTIVE, DISQUALIFIED PERSON AND INDIVIDUAL IN KEY POSITIONS. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE EXECUTIVE OR DISQUALIFIED PERSON CATEGORIES, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS ALONG WITH THE CONSULTANT'S COMPARABILITY DATA ARE PRESENTED TO THE JEC&BC FOR IT TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. EVERY THIRD YEAR THE INDEPENDENT CONSULTANT ANALYZES THE TOTAL EXECUTIVE COMPENSATION PROGRAM, USING THE SAME METHODOLOGY AS DESCRIBED ABOVE, THAT INCLUDEDS THE VALUE OF ALL BENEFITS AND PREREQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE EXECUTIVES AND DISQUALIFIED PERSONS. THE PURPOSE OF THE ANALYSIS IS TO PROVIDE AN OPINION ON THE REASONABLENESS OF EACH OF THE INDIVIDUAL COMPENSATION COMPONENTS AND THE AGGREGATE COMPENSATION TOTAL. THIS MORE COMPREHENSIVE ANALYSIS IS PROVIDED TO THE JEC&BC FOR THEIR USE IN THE ANNUAL REVIEW PROCESS. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE FULL BOARD. Form 990, Part VI, Section C, line 19 MOFFITT RESEARCH MAKES AVAILABLE TO THE PUBLIC THROUGH THIRD PARTY VENDORS' WEBSITES, ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS. FORM 990 IS MADE AVAILABLE ON GUIDESTAR WHILE THE AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON DACBOND. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. Form 990, Part VI, Section B, Line 14: THE ORGANIZATION HAS A WRITTEN DOCUMENT RETENTION AND DESTRUCTION POLICY WITH WHICH IT COMPLIES; HOWEVER, THE POLICY WAS NOT APPROVED BY THE BOARD OR A COMMITTEE BY THE FISCAL YEAR END. Form 990, Part VI, Section B, Line 16b: THE ORGANIZATION HAS ADOPTED A WRITTEN JOINT VENTURE PROCEDURE WITH WHICH IT COMPLIES; HOWEVER, IT WAS NOT APPROVED BY THE BOARD OR A COMMITTEE BY THE FISCAL YEAR END. PARENT/RESEARCH HAS ONE JOINT VENTURE AGREEMENT WITH PREMIER PURCHASING PARTNERS. Form 990, Part VII, Section A, Line 1a: NICOLAS C. PORTER RETIRED FROM MOFFITT IN MARCH 2011. Form 990, Part VII, Section A, Line 1b: DIRECTORS ESTIMATE OF AVERAGE HOURS PER WEEK DEVOTED TO RELATED ORGANIZATIONS TIMOTHY J. ADAMS: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 1HR DONALD D. BUCHANAN: MOFFITT GENETICS CORPORATION 1HR THEODORE J. COUCH: MOFFITT GENETICS CORPORATION 1HR EDWARD C DROSTE: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, FOUNDATION, INC. 1HR BENJAMIN H. HILL: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, FOUNDATION, INC. 1HR BETH A. HOUGHTON: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 1HR THE HONORABLE H. LEE MOFFITT: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 1HR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, FOUNDATION, INC. 1HR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 1HR MOFFITT GENETICS CORPORATION 1HR ROBERT ROTHMAN: MOFFITT GENETICS CORPORATION 1HR FORM 990, PART VII, SECTION A, LINE 1B: CURRENT & FORMER OFFICERS ESTIMATE OF AVERAGE HOURS PER WEEK DEVOTED TO RELATED ORGANIZATIONS JANENE CULUMBER H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 22HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. 4HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 5HRS MOFFITT TECHNOLOGIES CORPORATION 1HR MOFFITT GENETICS CORPORATION 6HRS WILLIAM S. DALTON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. 6HRS MOFFITT TECHNOLOGIES CORPORATION 1HR MOFFITT GENETICS CORPORATION 24HRS LOUIS D. DE LA PARTE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 22HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. 4HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 5HRS MOFFITT TECHNOLOGIES CORPORATION 1HR MOFFITT GENETICS CORPORATION 6HRS JOHN A. KOLOSKY H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 33HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. 4HRS MOFFITT TECHNOLOGIES CORPORATION 1HR ALAN F. LIST H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 30HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 15HRS YVETTE M. LYONS TREMONTI H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 32HRS MOFFITT TECHNOLOGIES CORPORATION 1HR LYNN C MOSCINSKI H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 54HRS JAMES J. MULAY MOFFITT TECHNOLOGIES CORPORATION 1HR DANIEL M. SULLIVAN H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 13HRS MOFFITT GENETICS CORPORATION 1HR TIMOTHY J. YEATMAN MOFFITT GENETICS CORPORATION 28HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 27HRS W. MICHAEL ALBERTS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 55HRS BRAULIO VICENTE JR. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 48HRS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING, INC. 7HRS JULIE Y. DJEU H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. 1HR Form 990, Part IX, Column (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE THE CONTRIBUTIONS ARE FROM RELATED ORGANIZATIONS, GOVERNMENT GRANTS, AND OTHER GRANTS. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBSIDIARIES. Changes in Net Assets or Fund Balances: Form 990, Part XI, line 5: Net unrealized gains on investments: 14840. PREMIER PARTNERSHIP INCOME -14970. INTEREST IN NET ASSETS OF FOUNDATION 2574482. DEFERRED REVENUE -88135. TRANSFER FROM TAX EXEMPT AFFILIATE 12055387. GRANT REFUNDS -493558. LOSS ON TEMPORARY INVESTMENTS -54111. Total to Form 990, Part XI, Line 5: 13993935. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(c)(3) Line 3 N/A 1 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(c)(3) Line 7 N/A 1 H LEE MOFFITT CC&RI LIFETIME CANCER SCREENING CENTER INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238640 PRACTICE MANAGEMENT FL 501(c)(3) Line 9 N/A 1 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL H LEE MOFFITT CC&RI INC C 49 264026 1.00000 MOFFITT GENETICS CORPORATION 10902 N MCKINLEY DRIVE TAMPA FL 33612 208486180 DATABASE MANAGEMENT FL H LEE MOFFITT CC&RI INC C -2286401 3658360 1.00000 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOFFITT GENETICS CORPORATION A 321212 FMV MOFFITT GENETICS CORPORATION A 36536 FMV H LEE MOFFITT CC&RI HOSPITAL INC B 232427 FMV H LEE MOFFITT CC&RI HOSPITAL INC C 5900004 FMV H LEE MOFFITT CC&RI FOUNDATION INC C 10989320 FMV H LEE MOFFITT CC&RI LCSC INC C 291482 FMV MOFFITT GENETICS CORPORATION C 791907 FMV H LEE MOFFITT CC&RI FOUNDATION INC D 3954739 FMV MOFFITT GENETICS CORPORATION D 3990852 FMV MOFFITT GENETICS CORPORATION D 1314586 FMV